Q4 2016 Holdings
Filed 2017-02-14 | 22 holdings | $47.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $46.1M | 3,224,046 | 97.9% |
| Inogen Inc(INGN) | COM | 45780L104 | $238.4K | 3,549,320 | 0.5% |
| Vanguard Index FDS(VTI) | TOTAL STK MKT | 922908769 | $187.2K | 1,623,100 | 0.4% |
| Colucid Pharmaceuticals Inc | COM | 19716T101 | $114.9K | 3,156,563 | 0.2% |
| Vanguard Intl Equity Index F(VGK) | FTSE EUROPE ETF | 922042874 | $100.7K | 2,101,000 | 0.2% |
| Reata Pharmaceuticals Inc(RETAEUR) | CL A | 75615P103 | $73.5K | 3,367,763 | 0.2% |
| Irhythm Technologies Inc(IRTC) | COM | 450056106 | $60.7K | 2,024,448 | 0.1% |
| Acceleron Pharma Inc(XLRN) | COM | 00434H108 | $31.6K | 1,240,173 | 0.1% |
| RA Pharmaceuticals Inc | COM | 74933V108 | $30.9K | 2,031,562 | 0.1% |
| Merus N V | COM | N5749R100 | $29.8K | 1,410,417 | 0.1% |
| Spectranetics Corp | COM | 84760C107 | $28.9K | 1,179,122 | 0.1% |
| Flexion Therapeutics Inc | COM | 33938J106 | $26.6K | 1,397,718 | 0.1% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $20.5K | 2,901,927 | 0.0% |
| Apollo Endosurgery Inc(HQ8F) | COM | 03767D108 | $17.7K | 1,456,972 | 0.0% |
| Nabriva Therapeutics AG | COM | 62957M104 | $13.9K | 2,326,544 | 0.0% |
| Invuity Inc | COM | 46187J205 | $7.6K | 1,318,448 | 0.0% |
| Dermira Inc(DERMEUR) | COM | 24983L104 | $6.6K | 216,562 | 0.0% |
| Wright MED Group N V | RIGHT 03/01/2019 | N96617126 | $6.1K | $4,622,032 | 0.0% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $4.5K | 223,317 | 0.0% |
| HTG Molecular Diagnostics Inc | COM | 40434H104 | $2.9K | 1,280,185 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $982 | 127,563 | 0.0% |
| Opko Health Inc(OPK) | COM | 68375N103 | $2 | 259 | 0.0% |